This is a preprint.
Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits
- PMID: 39211138
- PMCID: PMC11361146
- DOI: 10.1101/2024.07.27.605436
Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits
Abstract
Synaptogyrin-3, a functionally obscure synaptic vesicle protein, interacts with vesicular monoamine and dopamine transporters, bringing together dopamine release and reuptake sites. Synaptogyrin-3 was reduced by chronic cocaine exposure in both humans and rats, and synaptogyrin-3 levels inversely correlated with motivation to take cocaine in rats. Synaptogyrin-3 overexpression in dopamine neurons reduced cocaine self-administration, decreased anxiety-like behavior, and enhanced cognitive flexibility. Overexpression also enhanced nucleus accumbens dopamine signaling and prevented cocaine-induced deficits, suggesting a putative therapeutic role for synaptogyrin-3 in cocaine use disorder.